Loading…
Disclosed for 71 months, Nov 2020 to Sep 2026.
quant ESG Integration Strategy Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In January 2021 it disclosed 20 stocks worth ₹12.8 Cr, down ₹17 L from Dec 2020. Its largest positions were Fortis Healthcare Limited (9.3%), Bharti Airtel Limited (9.2%), Reliance Industries Limited (8.9%); the ten largest together made up 71.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 26.4% of its equity. Cash and debt stood at 5.2%. Compared with Dec 2020 the fund entered 7 new stocks and exited 7.
Top-10 weight is higher than 94% of peers
Holds more stocks than 5% of peers
Holds more cash than 72% of peers
What these mean: concentration · cash
Every line the fund disclosed, with the change against Dec 2020. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Fortis Healthcare Limited | 9.35% | up 0.59 pts | ₹1.2 Cr | up ₹6 L | Added |
| Bharti Airtel Limited | 9.19% | up 3.08 pts | ₹1.2 Cr | up ₹38 L | Added |
| Reliance Industries Limited | 8.93% | up 8.93 pts | ₹1.1 Cr | up ₹1.1 Cr | New |
| Oracle Financial Services Software Limited | 8.14% | up 8.14 pts | ₹1 Cr | up ₹1 Cr | New |
| Sun Pharmaceutical Industries Limited | 7.91% | up 1.04 pts | ₹1 Cr | up ₹12 L | Added |
| Infosys Limited | 6.60% | down 0.10 pts | ₹84 L | down ₹2 L | Trimmed |
| Divi's Laboratories Limited | 5.83% | down 0.73 pts | ₹74 L | down ₹10 L | Trimmed |
| Dabur India Limited | 5.64% | down 0.14 pts | ₹72 L | down ₹3 L | Trimmed |
| Alembic Pharmaceuticals Limited | 5.54% | down 0.39 pts | ₹71 L | down ₹6 L | Trimmed |
| Cash, TREPS & receivables | 5.22% | up 3.38 pts | ₹67 L | up ₹43 L | Added |
| Grasim Industries Limited | 4.53% | up 4.53 pts | ₹58 L | up ₹58 L | New |
| India Limited | 4.02% | up 0.19 pts | ₹51 L | up ₹2 L | Added |
| Fermenta Biotech Limited | 3.40% | down 0.19 pts | ₹43 L | down ₹3 L | Trimmed |
| Jyothy Labs Limited | 3.05% | up 3.05 pts | ₹39 L | up ₹39 L | New |
| Tech Mahindra Limited | 2.78% | down 3.47 pts | ₹35 L | down ₹45 L | Trimmed |
| Britannia Industries Limited | 2.74% | up 2.74 pts | ₹35 L | up ₹35 L | New |
| Jubilant Pharmova Limited | 2.34% | up 1.20 pts | ₹30 L | up ₹15 L | Added |
| Zydus Wellness Limited | 1.51% | down 0.03 pts | ₹19 L | down ₹1 L | Trimmed |
| Adani Ports and Special Economic Zone Limited | 1.48% | down 5.67 pts | ₹19 L | down ₹74 L | Trimmed |
| Aavas Financiers Limited | 1.42% | up 1.42 pts | ₹18 L | up ₹18 L | New |
| UltraTech Cement Limited | 0.38% | up 0.38 pts | ₹5 L | up ₹5 L | New |
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Compared with
Since Dec 2020, the weight rose most in Petroleum Products (+9.4 pts) and Cement & Cement Products (+5.2 pts), and fell most in IT - Software (−10.5 pts) and Transport Infrastructure (−5.7 pts).
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
| Sector | Dec 2020 | Jan 2021 |
|---|---|---|
| Pharmaceuticals & Biotechnology | 32.0% | 26.4% |
| IT - Software | 29.0% | 18.5% |
| Healthcare Services | 8.9% | 9.9% |
| Telecom - Services | 6.2% | 9.7% |
| Petroleum Products | — | 9.4% |
| Personal Products | 5.9% | 5.9% |
| Cement & Cement Products | — | 5.2% |
| Food Products | 1.6% | 4.5% |
| Power | 3.9% | 4.2% |
| Household Products | — | 3.2% |
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
| 2 |
| −2.0% |
| 4.7% |
| 7% |
| May 2026 | ₹294 Cr | 12 | 2 | 4 | −4.9% | 1.2% | 6% |
| Apr 2026 | ₹264 Cr | 14 | 3 | 5 | 0.6% | 6.7% | 6% |
| Mar 2026 | ₹226 Cr | 16 | 3 | 2 | −5.9% | 1.2% | 6% |
| Feb 2026 | ₹257 Cr | 15 | 5 | 2 | 0.8% | 6.6% | 6% |
| Jan 2026 | ₹252 Cr | 12 | 4 | 6 | −4.0% | 0.3% | 5% |
| Dec 2025 | ₹269 Cr | 14 | 4 | 7 | −5.1% | 0.4% | 5% |
| Nov 2025 | ₹273 Cr | 17 | 5 | 5 | 4.6% | 9.8% | 439% |
| Oct 2025 | ₹274 Cr | 17 | 5 | 5 | 5.3% | 9.7% | 386% |
| Sep 2025 | ₹277 Cr | 17 | 1 | 2 | −0.7% | 2.2% | 324% |
| Aug 2025 | ₹273 Cr | 18 | 3 | 2 | −4.6% | 0.2% | 327% |
| Jul 2025 | ₹285 Cr | 17 | 4 | 2 | −4.1% | 1.4% | 342% |
| Jun 2025 | ₹305 Cr | 15 | 2 | 0 | −4.1% | 0.4% | 357% |
| May 2025 | ₹299 Cr | 13 | 4 | 6 | −2.8% | 0.8% | 385% |
| Apr 2025 | ₹284 Cr | 15 | 2 | 6 | −1.9% | 0.8% | 392% |
| Mar 2025 | ₹277 Cr | 19 | 1 | 2 | −1.6% | 0.5% | 432% |
| Feb 2025 | ₹260 Cr | 20 | 8 | 4 | 0.7% | 0.7% | 439% |
| Jan 2025 | ₹288 Cr | 16 | 3 | 3 | 0.5% | 0.5% | 451% |
| Dec 2024 | ₹298 Cr | 16 | 1 | 5 | 3.3% | 3.3% | 470% |
| Nov 2024 | ₹312 Cr | 20 | 3 | 1 | 0.9% | 0.9% | 5% |
| Oct 2024 | ₹309 Cr | 18 | 4 | 1 | 1.6% | 1.6% | 5% |
For any of the 47 earlier months, choose it in “Portfolio as of” at the top of the page.